Thomas van Ee

433 total citations
8 papers, 230 citations indexed

About

Thomas van Ee is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Thomas van Ee has authored 8 papers receiving a total of 230 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in Thomas van Ee's work include Cancer Immunotherapy and Biomarkers (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Immune cells in cancer (3 papers). Thomas van Ee is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Immune cells in cancer (3 papers). Thomas van Ee collaborates with scholars based in Netherlands, United States and Italy. Thomas van Ee's co-authors include Nicole C.T. van Grieken, Yvette van Kooyk, Geert Kazemier, Ernesto Rodríguez, Laura Kruijssen, Elisa Giovannetti, Sven C. M. Bruijns, Joost C. van der Horst, Kari Brown and Matheus H. W. Crommentuijn and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Annals of Oncology.

In The Last Decade

Thomas van Ee

7 papers receiving 229 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas van Ee Netherlands	4	152	146	77	26	23	8	230
Kelly Boelaars Netherlands	4	161 1.1×	162 1.1×	77 1.0×	25 1.0×	27 1.2×	4	244
Mukulika Bose United States	8	143 0.9×	83 0.6×	117 1.5×	31 1.2×	16 0.7×	13	260
Jasper J. van Gemst Netherlands	6	216 1.4×	140 1.0×	40 0.5×	17 0.7×	29 1.3×	8	316
Christie Mortales United States	7	212 1.4×	227 1.6×	96 1.2×	56 2.2×	31 1.3×	9	372
Giulia Venturi Italy	9	240 1.6×	102 0.7×	29 0.4×	37 1.4×	28 1.2×	21	289
Natasja Balneger Netherlands	4	243 1.6×	212 1.5×	55 0.7×	22 0.8×	50 2.2×	5	335
Alicia Buck United States	7	83 0.5×	84 0.6×	65 0.8×	10 0.4×	21 0.9×	11	181
R. Maragliano Italy	3	99 0.7×	75 0.5×	164 2.1×	34 1.3×	31 1.3×	5	279
Mika Kamata‐Sakurai Japan	6	145 1.0×	81 0.6×	60 0.8×	11 0.4×	13 0.6×	10	218
Zachary T. Kneass United States	4	265 1.7×	131 0.9×	82 1.1×	26 1.0×	65 2.8×	4	354

Countries citing papers authored by Thomas van Ee

Since Specialization

Citations

This map shows the geographic impact of Thomas van Ee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas van Ee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas van Ee more than expected).

Fields of papers citing papers by Thomas van Ee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas van Ee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas van Ee. The network helps show where Thomas van Ee may publish in the future.

Co-authorship network of co-authors of Thomas van Ee

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas van Ee. A scholar is included among the top collaborators of Thomas van Ee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas van Ee. Thomas van Ee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Ee, Thomas van, Ernesto Rodríguez, Yongsoo Kim, et al.. (2025). Analysis of cancer-associated glycosyltransferases reveals novel targets of non-small cell lung cancer pathogenesis. Frontiers in Oncology. 15. 1601368–1601368. 1 indexed citations

Ee, Thomas van, Alsya J. Affandi, Ernesto Rodríguez, et al.. (2023). Spatial immune composition of tumor microenvironment in patients with pancreatic cancer. Cancer Immunology Immunotherapy. 72(12). 4385–4397. 8 indexed citations

Ee, Thomas van, Arantza Fariña Sarasqueta, Johanna W. Wilmink, et al.. (2023). The immune microenvironment after neoadjuvant therapy compared to upfront surgery in patients with pancreatic cancer. Journal of Cancer Research and Clinical Oncology. 149(16). 14731–14743.

Wilpe, Sandra van, Donjetë Simnica, Thomas van Ee, et al.. (2022). Homologous recombination repair deficient prostate cancer represents an immunologically distinct subtype. OncoImmunology. 11(1). 9 indexed citations

Rodríguez, Ernesto, Kelly Boelaars, Kari Brown, et al.. (2021). Sialic acids in pancreatic cancer cells drive tumour-associated macrophage differentiation via the Siglec receptors Siglec-7 and Siglec-9. Nature Communications. 12(1). 1270–1270. 191 indexed citations

Caam, A. van, Thomas van Ee, E.L. Vitters, et al.. (2020). TGFβ-mediated expression of TGFβ-activating integrins in SSc monocytes: disturbed activation of latent TGFβ?. Arthritis Research & Therapy. 22(1). 42–42. 18 indexed citations

Mehra, Niven, Job van Riet, Minke Smits, et al.. (2018). In-depth assessment of metastatic prostate cancer with high tumour mutational burden. Annals of Oncology. 29. viii274–viii274. 2 indexed citations

Smits, Minke, Harm Westdorp, Mark A.J. Gorris, et al.. (2018). Correlates of response to anti-PD-1 immune checkpoint blockade (ICB) in mismatch repair proficient (MMRp) and deficient (MMRd) patients (pts) with metastatic castration resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 36(15_suppl). 5036–5036. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact